Liabilities / Assets
64th percentile
Higher debt load relative to assets than 64% of similar nonprofits.
990 • Fiscal year 2023 • EIN 47-1981973
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
64th percentile
Higher debt load relative to assets than 64% of similar nonprofits.
Liabilities / Revenue
58th percentile
Higher debt load relative to revenue than 58% of similar nonprofits.
Net Margin
9th percentile
Higher net margin than 9% of similar nonprofits.
Top Officer Pay
92nd percentile
Higher top officer pay than 92% of similar nonprofits.
Top officer pay equals 5.0% of source-year revenue.
Asset Growth
3rd percentile
Faster asset growth than 3% of similar nonprofits.
Revenue Growth
10th percentile
Faster revenue growth than 10% of similar nonprofits.
Assets
Down$11,743,398
Down $3,843,953 (-25%) from 2022
Net Assets
Down$7,889,693
Down $3,997,832 (-34%) from 2022
Liabilities
Up$3,853,705
Up $153,879 (+4.2%) from 2022
Revenue
Down$11,343,534
Down $6,738,864 (-37%) from 2022
Expenses
Down$15,341,366
Down $2,182,418 (-12%) from 2022
Net Income
Down-$3,997,832
Down $4,556,446 (-816%) from 2022
Cohen veterans bioscience is the only 501(c)3 non-profit research organization with a singular focus on ptsd and tbi research. We are dedicated to fast-tracking the development of diagnostic tests and personalized medicines for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.
Biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Savings and Temporary Cash Investments | $3,831,713 | $5,471,810 | ▲ $1,640,097 |
| Land, Buildings, and Equipment, Net | $1,432,920 | $1,967,457 | ▲ $534,537 |
| Pledges and Grants Receivable | $8,295,108 | $1,762,522 | ▼ $6,532,586 |
| Cash and Non-Interest-Bearing Accounts | $999,648 | $828,606 | ▼ $171,042 |
| Prepaid Expenses and Deferred Charges | $123,073 | $98,344 | ▼ $24,729 |
| Accounts Receivable | $21,300 | - | - |
| Total Assets | $15,587,351 | $11,743,398 | ▼ $3,843,953 |
| Other Assets Total | $883,589 | $1,614,659 | ▲ $731,070 |
| Liabilities | |||
| Accounts Payable and Accrued Expenses | $2,682,753 | $1,818,611 | ▼ $864,142 |
| Other Liabilities | $139,342 | $1,294,809 | ▲ $1,155,467 |
| Deferred Revenue | $740,285 | $740,285 | → $0 |
| Grants Payable | $137,446 | - | - |
| Total Liabilities | $3,699,826 | $3,853,705 | ▲ $153,879 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $7,257,190 | $5,480,842 | ▼ $1,776,348 |
| Net Assets With Donor Restrictions | $4,630,335 | $2,408,851 | ▼ $2,221,484 |
| Total Net Assets Fund Balance | $11,887,525 | $7,889,693 | ▼ $3,997,832 |
| Total Liabilities and Net Assets / Fund Balance | $15,587,351 | $11,743,398 | ▼ $3,843,953 |
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Other Land Buildings | $1,826,934 | $373,112 | $2,200,046 |
| Equipment | $74,997 | $99,079 | $174,076 |
| Leasehold Improvements | $65,526 | $68,836 | $134,362 |
| Other Assets Org | $415,451 | - | - |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Magali Haas Md Phd | CEO & President | FT | $473,560 | $92,175 | $565,735 |
| Allyson Gage Phd | Chief Medical Officer | FT | $384,589 | $119,782 | $504,371 |
| Amanda Nicole Harmon | Chief Operations Officer | FT | $283,405 | $117,761 | $401,166 |
| Lee Lancashire | Chief Information Officer | FT | $310,941 | $57,367 | $368,308 |
| Evgeny Rakhmatulin | Chief Technology Officer | FT | $241,822 | $102,694 | $344,516 |
| Maryan Zirkle | Executive Director, Brainc | FT | $238,362 | $68,663 | $307,025 |
| Mark Zervas | Deputy Director, Translati | FT | $188,176 | $65,171 | $253,347 |
| Lauren Goldsmith | Senior Director, Contracts | FT | $227,944 | $24,610 | $252,554 |
| Renee Davis | Executive Director, Develo | FT | $208,434 | $18,344 | $226,778 |
| Peter Hoehn | Executive VP, Marking Strategy, Develop, & Impact | FT | $183,750 | - | $183,750 |
| Peter Hoehn | Executive VP, Marking Strategy, Deve | - | $141,346 | $42,404 | $183,750 |
| Andrew Thompson | Associate Director, Data Science | FT | $159,579 | $18,005 | $177,584 |
| Name | Title |
|---|---|
| Dave Demarco | Board Member |
| David Biondi | Board Member |
| Theresa Frangiosa | Secretary |
| Michael Sullivan | Treasurer |
| Contractor | Services | Location | Compensation |
|---|---|---|---|
| Waveaccess USA | Provide Resources For Brain Commons And | 10161 WEST RUN PARK DRIVE SUITE 15, Las Vegas, NV 89145 | $596,186 |
| Iconic Event Studios INC | Event Coordination | 1861 SUNSET PLAZA DRIVE, Los Angeles, CA 90069 | $477,417 |
| Hitachi Vantara LLC | Rean And Bc | 2535 AUGUSTINE DRIVE, Santa Clara, CA 95054-3003 | $420,000 |
| Grf Cpa's & Advisors | Accounting Services | 4550 MONTGOMERY AVENUE SUITE 800 N, Bethesda, MD 20814 | $342,803 |
| Tone Creative LLC | Marketing And Design Services | 63 PUTNAM STREET SUITE 202, Sarasota Springs, NY 12866 | $273,270 |
| Line Item | Amount |
|---|---|
| Other Expenses | $8,383,425 |
| Salaries, Compensation, and Employee Benefits | $6,759,744 |
| Total Fundraising Expense | $430,116 |
| Grants and Similar Amounts Paid | $198,197 |
| Professional Fundraising Fees | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Fees for Services Other | $4,584,048 | $222,134 | $21,188 | $4,827,370 |
| Other Salaries and Wages | $2,798,978 | $178,570 | $194,367 | $3,171,915 |
| Current Officers, Directors, Trustees, and Key Employees | $2,461,672 | $136,427 | $150,001 | $2,748,100 |
| Occupancy | $500,366 | $24,560 | $63 | $524,989 |
| Information Technology | $510,664 | $5,049 | $2,429 | $518,142 |
| Office Expenses | $319,644 | $169,622 | $7,706 | $496,972 |
| Travel | $441,230 | $17,090 | $3,161 | $461,481 |
| Fees for Services Accounting | $6,320 | $408,678 | - | $414,998 |
| Depreciation Depletion | $340,599 | $2,097 | $2,291 | $344,987 |
| Other Employee Benefits | $304,762 | $16,524 | $18,025 | $339,311 |
| Fees for Services Legal | $229,420 | $88,480 | - | $317,900 |
| Payroll Taxes | $284,374 | $15,503 | $16,945 | $316,822 |
| Conferences and Meetings | $249,121 | $2,775 | - | $251,896 |
| Pension Plan Contributions | $164,976 | $8,912 | $9,708 | $183,596 |
| Fees for Services Lobbying | $120,000 | - | - | $120,000 |
| Grants to Domestic Orgs | $108,171 | - | - | $108,171 |
| Insurance | $71,023 | $29,435 | $4,232 | $104,690 |
| Foreign Grants | $90,026 | - | - | $90,026 |
| Total Functional Expenses | $13,585,394 | $1,325,856 | $430,116 | $15,341,366 |
| Line Item | Amount |
|---|---|
| Expenses per Audited Statements | $15,341,366 |
| Total Expenses per Audited Statements | $15,341,366 |
| Total Expenses per Form 990 | $15,341,366 |
| Expenses Not Reported on Financial Statements | $0 |
| Expenses Not Reported on Form 990 | $0 |
| Recipient | Location | Category | Purpose | Amount |
|---|---|---|---|---|
| University of California San Diego | La Jolla, CA | 501(c)3 | ALCOHOL-PTSD COMORBIDITY: PRECLINICAL STUDIES | $108,171 |
| Region | Activity | Services | Offices | Employees | Spending |
|---|---|---|---|---|---|
| Europe (including Iceland & Greenland) - Albania, Andorra, Austria, Belgium | Grants to Recipients Located in Region | N/a | 0 | 0 | $90,026 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
| Liability | Amount |
|---|---|
| Operating Lease Liability | $1,294,809 |
“The form 990 was reviewed by the organization's outsourced cfo and then reviewed, authorized and signed by the organization's ceo & president.”
“The board of directors requires an annual declaration from all board members and senior management as to the existence and disclosure of any potential conflicts of interest. The board members sign a disclosure statement. Any potential conflicts are discussed by the dis-interested board members, while the party in potential conflict is required to leave the room. Board meeting minutes will document the discussion and decision making process. In the event of a potential conflict, procedures to obtain competitive bids and diligence on fair market value will be established.”
“Cvb's executive compensation program is administered by the board of directors. The board is responsible for establishing and maintaining a competitive compensation program for the key executives of the organization. The board meets as needed to review the compensation program and make recommendations for any changes, as appropriate. A performance evaluation is conducted and reviewed each year and is intended to ensure that the compensation program falls within a reasonable range of competitive practices for comparable positions among similarly situated organizations. Following this review, the board reviews and approves, for selected key executives, base salaries and annual incentive opportunity adjustments, and objectives and goals upcoming year's annual incentive plan. The board reviews and recommends to the board salary approval and incentive awards for the ceo/president and selected key senior staff.”
“Upon request and forms available through charity navigator website as well.”
“Other professional fees: program service expenses 0. Management and general expenses 183,849. Fundraising expenses 0. Total expenses 183,849. Research collaboration expenses: program service expenses 597,783. Management and general expenses 0. Fundraising expenses 0. Total expenses 597,783. Contracted services: program service expenses 3,986,265. Management and general expenses 38,285. Fundraising expenses 21,188. Total expenses 4,045,738.”
“Tax position: the organization currently evaluates all tax positions and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax position made by the organization is the existence of unrelated business income tax and the organization's status as a tax-exempt public charity under irc section 501(c)(3). For the year presented, the organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation.”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | 0 |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 2682753 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 1818611 |
| IRS990/AccountsReceivableGrp/BOYAmt | 0 | 21300 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | 0 |
| IRS990/ActivityOrMissionDesc | 0 | BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS. |
| IRS990/AllOtherContributionsAmt | 0 | 10755381 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | 1 |
| IRS990/AuditCommitteeInd | 0 | 1 |
| IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | GELMAN ROSENBERG AND FREEDMAN CPA |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 3019519090 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 4550 MONTGOMERY AVENUE SUITE 650N |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | BETHESDA |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | MD |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 20814 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | 0 |
| IRS990/BusinessRlnWithFamMemInd | 0 | 0 |
| IRS990/BusinessRlnWithOrgMemInd | 0 | 0 |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 999648 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 828606 |
| IRS990/ChangeToOrgDocumentsInd | 0 | 0 |
| IRS990/CntrctRcvdGreaterThan100KCnt | 0 | 20 |
| IRS990/CollectionsOfArtInd | 0 | 0 |
| IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt | 0 | 150001 |
| IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt | 0 | 136427 |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 2461672 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 2748100 |
| IRS990/CompensationFromOtherSrcsInd | 0 | 0 |
| IRS990/CompensationProcessCEOInd | 0 | 1 |
| IRS990/CompensationProcessOtherInd | 0 | 1 |
| IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt | 0 | 2775 |
| IRS990/ConferencesMeetingsGrp/ProgramServicesAmt | 0 | 249121 |
| IRS990/ConferencesMeetingsGrp/TotalAmt | 0 | 251896 |
| IRS990/ConflictOfInterestPolicyInd | 0 | 1 |
| IRS990/ConservationEasementsInd | 0 | 0 |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | 0 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 0 | 596186 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 1 | 477417 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 2 | 420000 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 3 | 342803 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 4 | 273270 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 0 | 10161 WEST RUN PARK DRIVE SUITE 15 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 1 | 1861 SUNSET PLAZA DRIVE |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 2 | 2535 AUGUSTINE DRIVE |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 3 | 4550 MONTGOMERY AVENUE SUITE 800 N |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 4 | 63 PUTNAM STREET SUITE 202 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 0 | LAS VEGAS |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 1 | LOS ANGELES |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 2 | SANTA CLARA |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 3 | BETHESDA |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 4 | SARASOTA SPRINGS |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 0 | NV |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 1 | CA |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 2 | CA |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 3 | MD |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 4 | NY |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 0 | 89145 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 1 | 90069 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 2 | 950543003 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 3 | 20814 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 4 | 12866 |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 0 | WAVEACCESS USA |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 1 | ICONIC EVENT STUDIOS INC |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 2 | HITACHI VANTARA LLC |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 3 | GRF CPA'S & ADVISORS |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 4 | TONE CREATIVE LLC |
| IRS990/ContractorCompensationGrp/ServicesDesc | 0 | PROVIDE RESOURCES FOR BRAIN COMMONS AND |
| IRS990/ContractorCompensationGrp/ServicesDesc | 1 | EVENT COORDINATION |
| IRS990/ContractorCompensationGrp/ServicesDesc | 2 | REAN AND BC |
| IRS990/ContractorCompensationGrp/ServicesDesc | 3 | ACCOUNTING SERVICES |
| IRS990/ContractorCompensationGrp/ServicesDesc | 4 | MARKETING AND DESIGN SERVICES |
| IRS990/CreditCounselingInd | 0 | 0 |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 10755381 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 198197 |
| IRS990/CYInvestmentIncomeAmt | 0 | 223966 |
| IRS990/CYOtherExpensesAmt | 0 | 8383425 |
| IRS990/CYOtherRevenueAmt | 0 | 364187 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -3997832 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 6759744 |
| IRS990/CYTotalExpensesAmt | 0 | 15341366 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 430116 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 11343534 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | 0 |
| IRS990/DeductibleArtContributionInd | 0 | 0 |
| IRS990/DeductibleNonCashContriInd | 0 | 0 |
| IRS990/DeferredRevenueGrp/BOYAmt | 0 | 740285 |
| IRS990/DeferredRevenueGrp/EOYAmt | 0 | 740285 |
| IRS990/DelegationOfMgmtDutiesInd | 0 | 0 |
| IRS990/DepreciationDepletionGrp/FundraisingAmt | 0 | 2291 |
| IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt | 0 | 2097 |
| IRS990/DepreciationDepletionGrp/ProgramServicesAmt | 0 | 340599 |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 344987 |
| IRS990/Desc | 0 | BRAIN HEALTH TOOLS & TECHNOLOGIES:IN ORDER TO FAST-TRACK PRECISION DIAGNOSTICS AND TARGETED THERAPEUTICS AND WELLNESS APPROACHES FOR MAINTENANCE AND RESTORATION OF BRAIN HEALTH, CVB IS LEVERAGING INNOVATION AND TECHNOLOGY TO BUILD TOOLS AND PLATFORMS THAT ENABLE DISCOVERY AND DEVELOPMENT ACROSS BRAIN DISEASES. THESE TOOLS & PLATFORMS ALLOW RESEARCHERS FROM ACADEMIA AND INDUSTRY TO ACCESS AND UTILIZE BEST-IN-CLASS PRACTICES AND ALLOW EFFORTS TO BE SCALED WITH RIGOR AND REPRODUCIBILITY.(SEE SCHEDULE O FOR FULL DETAIL OF OUR PROGRAMS)PLATFORM EFFORTS FOCUS ON CAPACITY THAT ENABLES RELIABLE DISCOVERY OF BIOMARKERS AND BIOLOGICAL PATHWAYS THAT ARE TRANSLATIONALLY RELEVANT FOR THE DEVELOPMENT OF DIAGNOSTICS AND THERAPEUTIC TARGETS FOR DRUG AND OTHER MEDICAL INTERVENTIONS. EACH PLATFORM IS CREATING RESEARCH TOOLS (E.G. ANIMAL MODELS, DATA STANDARDS, COMPUTATIONAL MODELS, REFERENCE DATABASES, ETC.) THAT WILL ACCELERATE/FOSTER THESE DISCOVERIES.WITHIN THIS FRAMEWORK, CVB HAS ESTABLISHED BOTH INTRAMURAL (RESEARCH CONDUCTED BY, OR INCLUDING, CVB STAFF OR CONTRACTORS) AND EXTRAMURAL RESEARCH PROGRAMS (RESEARCH CONDUCTED VIA GRANTS OR IN COLLABORATION WITH EXTERNAL ACADEMIC, INDUSTRY, FOUNDATION AND GOVERNMENT PARTNERS) AND ALSO OPERATES SEVERAL PUBLIC-PRIVATE PARTNERSHIPS. THESE COOPERATIVE ALLIANCES ORGANIZE AND FUND A NETWORK OF PARTNERS WHO EACH CONTRIBUTE COMPLEMENTARY AND SYNERGISTIC DATA, CAPABILITIES, OR EXPERTISE TO SUPPORT A COMMON ROADMAP FOR IDENTIFYING DIAGNOSTIC BIOMARKERS, BUILDING PREDICTIVE BRAIN DISEASE MODELS, DEVELOPING ROBUST STANDARDIZED TRANSLATIONAL TOOLS, AND CATALYZING PHARMACEUTICAL DRUG DEVELOPMENT. THE EMPHASIS IS ON TEAM SCIENCE WITH COHEN VETERANS BIOSCIENCE SERVING AS ITS HUB.OUR PLATFORM PROGRAMS CURRENTLY INCLUDE THE BRAINCOMMONS (CLOUD-BASED DATA & ANALYTICS), EARLYSIGNAL (WEARABLE AND HOME SENSORS FOR MONITORING HEALTH STATUS), RAPID-DX (ESTABLISHING BEST PRACTICES FOR DISCOVERY AND VALIDATION OF BIOMARKERS), AMP-IT-UP (FOR PRECLINICAL DISCOVERY AND TRANSLATION) AND TAP (TARGET ADVANCEMENT PROGRAM).BRAINCOMMONS:THE BRAINCOMMONS (BC) IS A CLOUD-BASED RESEARCH AND DISCOVERY PLATFORM FOR THE BRAIN HEALTH COMMUNITY WHICH FEATURES DATA, TOOLS, AND COMMUNITY ACCESS IN A SECURE, SCALABLE, AND SUSTAINABLE ENVIRONMENT. IT IS DESIGNED TO FURTHER DEMOCRATIZE DATA AND ENABLE GREATER COLLABORATION GLOBALLY AMONG BRAIN SCIENTISTS WORKING IN A VARIETY OF SETTINGS.WE ARE IN A NEW ERA OF BRAIN RESEARCH, WHERE POWERFUL DATA ACQUISITION TECHNOLOGIES ARE GENERATING MULTIMODAL DATA AT INCREASING SCALES. TO ENABLE DISEASE MODELING EFFORTS, AS WELL AS THE DISCOVERY AND REPLICATION OF BIOMARKERS, THERE IS A CRITICAL NEED FOR A PLATFORM THAT CAN HOUSE MULTI-MODAL DATA TYPES, ACROSS DIAGNOSTIC CATEGORIES, IN CONJUNCTION WITH DATA PIPELINES TO ENSURE REPRODUCIBLE ANALYSIS, AND WITH AN ABILITY TO APPLY STATE-OF-THE ART MACHINE-LEARNING ALGORITHMS. IN 2022, THE BRAINCOMMONS WAS LAUNCHED TO OUR FIRST COMMUNITY OF RESEARCH PARTNERS IN PTSD, TBI AND PARKINSON'S.IN 2023, WE HAVE LAUNCHED A NEW USER INTERFACE FOR THE BRAINCOMMONS AND HAVE UPLOADED OUR NATIONAL NORMATIVE NEUROIMAGING LIBRARY DATA TO THE PLATFORM TO BE SHARED WITH THE RESEARCH COMMUNITY WITH ACCOMPANYING PIPELINES FOR DATA PROCESSING.EARLYSIGNAL:THE AIM OF OUR DIGITAL HEALTH PROGRAM, EARLY SIGNAL, IS TO RECORD AND ANALYZE A RANGE OF DATA DIRECTLY RELATED TO THE WELL-BEING OF PATIENTS LIVING WITH BRAIN DISORDERS. BEHAVIORAL, COGNITIVE, PHYSIOLOGICAL AND OTHER INFORMATION ARE COLLECTED THROUGH OUR INTEGRATED TECHNOLOGY PLATFORM.WEARABLE AND SENSOR TECHNOLOGIES HOLD PROMISE IN THE ASSESSMENT AND CONTINUOUS MONITORING OF PATIENTS IN ORDER TO BETTER SCREEN AND DIAGNOSE, MONITOR DISEASE PROGRESSION, AND OBSERVE INTERVENTION RESPONSE OR LACK THEREOF. DIGITAL HEALTH MONITORING ALSO ALLOWS US TO STUDY BRAIN HEALTH AND DISEASE IN UNPRECEDENTED WAYS, BY TRACKING VARIABLES SUCH AS SLEEP, PHYSICAL ACTIVITY, STRESS AND COGNITION, WE MAY BE ABLE TO BETTER UNDERSTAND WHAT CHANGES OVER TIM |
| IRS990/DescribedInSection501c3Ind | 0 | 1 |
| IRS990/DisregardedEntityInd | 0 | 1 |
| IRS990/DocumentRetentionPolicyInd | 0 | 1 |
| IRS990/DonorAdvisedFundInd | 0 | 0 |
| IRS990/DonorRestrictionNetAssetsGrp/BOYAmt | 0 | 4630335 |
| IRS990/DonorRestrictionNetAssetsGrp/EOYAmt | 0 | 2408851 |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | 0 |
| IRS990/ElectionOfBoardMembersInd | 0 | 0 |
| IRS990/EmployeeCnt | 0 | 36 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | 1 |
| IRS990/EngagedInExcessBenefitTransInd | 0 | 0 |
| IRS990/ExpenseAmt | 0 | 13585394 |
| IRS990/FamilyOrBusinessRlnInd | 0 | 0 |
| IRS990/FederalGrantAuditRequiredInd | 0 | 0 |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 408678 |
| IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt | 0 | 6320 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 414998 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 88480 |
| IRS990/FeesForServicesLegalGrp/ProgramServicesAmt | 0 | 229420 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 317900 |
| IRS990/FeesForServicesLobbyingGrp/ProgramServicesAmt | 0 | 120000 |
| IRS990/FeesForServicesLobbyingGrp/TotalAmt | 0 | 120000 |
| IRS990/FeesForServicesOtherGrp/FundraisingAmt | 0 | 21188 |
| IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt | 0 | 222134 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 4584048 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 4827370 |
| IRS990/ForeignActivitiesInd | 0 | 1 |
| IRS990/ForeignFinancialAccountInd | 0 | 0 |
| IRS990/ForeignGrantsGrp/ProgramServicesAmt | 0 | 90026 |
| IRS990/ForeignGrantsGrp/TotalAmt | 0 | 90026 |
| IRS990/ForeignOfficeInd | 0 | 1 |
| IRS990/Form8282PropertyDisposedOfInd | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 9.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 6 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 7 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 8 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 9 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 10 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 11 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 12 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 13 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 14 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 18300 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 57367 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 6 | 22635 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 7 | 36449 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 8 | 38944 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 10 | 22610 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 11 | 36101 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 12 | 25337 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 13 | 18344 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 14 | 18005 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | MAGALI HAAS MD PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | THERESA FRANGIOSA |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | MICHAEL SULLIVAN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | DAVID BIONDI |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | DAVE DEMARCO |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | LEE LANCASHIRE |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 6 | ALLYSON GAGE PHD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 7 | AMANDA NICOLE HARMON |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 8 | EVGENY RAKHMATULIN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 9 | PETER HOEHN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 10 | LAUREN GOLDSMITH |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 11 | MARK ZERVAS |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 12 | MARYAN ZIRKLE |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 13 | RENEE DAVIS |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 14 | ANDREW THOMPSON |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 547435 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 310941 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 6 | 481736 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 7 | 364717 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 8 | 305572 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 9 | 183750 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 10 | 229944 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 11 | 217246 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 12 | 281688 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 13 | 208434 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 14 | 159579 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 8 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 9 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 10 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 11 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 12 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 13 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 14 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | CEO & PRESIDENT |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | SECRETARY |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | TREASURER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | CHIEF INFORMATION OFFICER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 6 | CHIEF MEDICAL OFFICER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 7 | CHIEF OPERATIONS OFFICER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 8 | CHIEF TECHNOLOGY OFFICER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 9 | EXECUTIVE VP, MARKING STRATEGY, DEVELOP, & IMPACT |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 10 | SENIOR DIRECTOR, CONTRACTS |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 11 | DEPUTY DIRECTOR, TRANSLATI |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 12 | EXECUTIVE DIRECTOR, BRAINC |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 13 | EXECUTIVE DIRECTOR, DEVELO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 14 | ASSOCIATE DIRECTOR, DATA SCIENCE |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | 1 |
| IRS990/FormationYr | 0 | 2014 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | 0 |
| IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd | 0 | X |
| IRS990/FSAuditedInd | 0 | 1 |
| IRS990/FundraisingActivitiesInd | 0 | 0 |
| IRS990/GamingActivitiesInd | 0 | 0 |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 5 |
| IRS990/GrantAmt | 0 | 198197 |
| IRS990/GrantsPayableGrp/BOYAmt | 0 | 137446 |
| IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt | 0 | 108171 |
| IRS990/GrantsToDomesticOrgsGrp/TotalAmt | 0 | 108171 |
| IRS990/GrantsToIndividualsInd | 0 | 0 |
| IRS990/GrantsToOrganizationsInd | 0 | 1 |
| IRS990/GrantToRelatedPersonInd | 0 | 0 |
| IRS990/GrossReceiptsAmt | 0 | 11343534 |
| IRS990/GroupReturnForAffiliatesInd | 0 | 0 |
| IRS990/IncludeFIN48FootnoteInd | 0 | 1 |
| IRS990/IndependentAuditFinclStmtInd | 0 | 1 |
| IRS990/IndependentVotingMemberCnt | 0 | 4 |
| IRS990/IndivRcvdGreaterThan100KCnt | 0 | 20 |
| IRS990/IndoorTanningServicesInd | 0 | 0 |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartIXInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIIInd | 0 | X |
| IRS990/InformationTechnologyGrp/FundraisingAmt | 0 | 2429 |
| IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt | 0 | 5049 |
| IRS990/InformationTechnologyGrp/ProgramServicesAmt | 0 | 510664 |
| IRS990/InformationTechnologyGrp/TotalAmt | 0 | 518142 |
| IRS990/InsuranceGrp/FundraisingAmt | 0 | 4232 |
| IRS990/InsuranceGrp/ManagementAndGeneralAmt | 0 | 29435 |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 71023 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 104690 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 223966 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 223966 |
| IRS990/InvestmentInJointVentureInd | 0 | 0 |
| IRS990/IRPDocumentCnt | 0 | 32 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 541027 |
| IRS990/LandBldgEquipBasisNetGrp/BOYAmt | 0 | 1432920 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 1967457 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 2508484 |
| IRS990/LegalDomicileStateCd | 0 | MA |
| IRS990/LoanOutstandingInd | 0 | 0 |
| IRS990/LobbyingActivitiesInd | 0 | 1 |
| IRS990/LocalChaptersInd | 0 | 0 |
| IRS990/MaterialDiversionOrMisuseInd | 0 | 0 |
| IRS990/MembersOrStockholdersInd | 0 | 0 |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | 1 |
| IRS990/MinutesOfGoverningBodyInd | 0 | 1 |
| IRS990/MissionDesc | 0 | COHEN VETERANS BIOSCIENCE, INC. IS A NON-PROFIT 501(C)(3) BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | 0 |
| IRS990/MoreThan5000KToOrgInd | 0 | 1 |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 11887525 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 7889693 |
| IRS990/NetUnrelatedBusTxblIncmAmt | 0 | 0 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 7257190 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 5480842 |
| IRS990/NondeductibleContributionsInd | 0 | 0 |
| IRS990/OccupancyGrp/FundraisingAmt | 0 | 63 |
| IRS990/OccupancyGrp/ManagementAndGeneralAmt | 0 | 24560 |
| IRS990/OccupancyGrp/ProgramServicesAmt | 0 | 500366 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 524989 |
| IRS990/OfficeExpensesGrp/FundraisingAmt | 0 | 7706 |
| IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt | 0 | 169622 |
| IRS990/OfficeExpensesGrp/ProgramServicesAmt | 0 | 319644 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 496972 |
| IRS990/OfficerMailingAddressInd | 0 | 0 |
| IRS990/OperateHospitalInd | 0 | 0 |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 883589 |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 1614659 |
| IRS990/OtherChangesInNetAssetsAmt | 0 | 0 |
| IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt | 0 | 18025 |
| IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt | 0 | 16524 |
| IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt | 0 | 304762 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 339311 |
| IRS990/OtherLiabilitiesGrp/BOYAmt | 0 | 139342 |
| IRS990/OtherLiabilitiesGrp/EOYAmt | 0 | 1294809 |
| IRS990/OtherRevenueMiscGrp/BusinessCd | 0 | 900099 |
| IRS990/OtherRevenueMiscGrp/BusinessCd | 1 | 900099 |
| IRS990/OtherRevenueMiscGrp/Desc | 0 | GRANT REFUNDS |
| IRS990/OtherRevenueMiscGrp/Desc | 1 | OTHER REFUNDS |
| IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt | 0 | 326982 |
| IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt | 1 | 37205 |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 0 | 326982 |
| IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt | 1 | 37205 |
| IRS990/OtherRevenueTotalAmt | 0 | 364187 |
| IRS990/OtherSalariesAndWagesGrp/FundraisingAmt | 0 | 194367 |
| IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt | 0 | 178570 |
| IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt | 0 | 2798978 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 3171915 |
| IRS990/OtherWebsiteInd | 0 | X |
| IRS990/PartialLiquidationInd | 0 | 0 |
| IRS990/PayPremiumsPrsnlBnftCntrctInd | 0 | 0 |
| IRS990/PayrollTaxesGrp/FundraisingAmt | 0 | 16945 |
| IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt | 0 | 15503 |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 284374 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 316822 |
| IRS990/PensionPlanContributionsGrp/FundraisingAmt | 0 | 9708 |
| IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt | 0 | 8912 |
| IRS990/PensionPlanContributionsGrp/ProgramServicesAmt | 0 | 164976 |
| IRS990/PensionPlanContributionsGrp/TotalAmt | 0 | 183596 |
| IRS990/PledgesAndGrantsReceivableGrp/BOYAmt | 0 | 8295108 |
| IRS990/PledgesAndGrantsReceivableGrp/EOYAmt | 0 | 1762522 |
| IRS990/PoliticalCampaignActyInd | 0 | 0 |
| IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt | 0 | 123073 |
| IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt | 0 | 98344 |
| IRS990/PrincipalOfficerNm | 0 | MAGALI HAAS MD PHD |
| IRS990/ProfessionalFundraisingInd | 0 | 0 |
| IRS990/ProgSrvcAccomActy2Grp/Desc | 0 | THE STATE OF THE SCIENCE SUMMITS ARE THE BASIS FOR BUILDING THE ROADMAPS AND ARE DESIGNED AS RETREATS FOR 100 TO 200 STAKEHOLDERS TO COME TOGETHER TO REALIZE TRUE IMPACT. THE STAKEHOLDERS ENCOMPASS A BROAD SWATH OF THE COMMUNITY FROM ACADEMIC INSTITUTIONS TO GOVERNMENT AGENCIES, FOUNDATIONS SUPPORTING TRANSLATIONAL RESEARCH, INDUSTRY AND INDIVIDUALS WITH LIVED EXPERIENCE.EACH SUMMIT SERVES AS A LAUNCHPAD FOR ONGOING WORKING GROUPS TO DEVELOP EVIDENCE-BASED STRATEGIES AND RECOMMENDATIONS ON HOW TO FILL THOSE GAPS, IDENTIFY NEW GAPS AS OTHERS ARE FILLED, AND DISSEMINATE THESE FINDINGS BACK TO THE COMMUNITY AT LARGE THROUGH WHITE PAPERS AND PROCEEDINGS.THE INAUGURAL STATE OF THE SCIENCE SUMMIT ("SOSS"), HELD IN 2018, FOCUSED ON DIAGNOSIS OF TRAUMA-RELATED BRAIN DISORDERS WITH A MAJOR FOCUS ON POST-TRAUMATIC STRESS DISORDER. THE TRAUMA-RELATED BRAIN DISORDERS RESEARCH COMMUNITY HAS IDENTIFIED A NEED TO ESTABLISH A MECHANISM-BASED TAXONOMY FOR THESE CONDITIONS TO ADVANCE BIOMARKER DISCOVERY AS WELL AS DIAGNOSIS AND THERAPEUTIC DEVELOPMENT. A SHIFT FROM A SYNDROMIC CLASSIFICATION SYSTEM TO A MECHANISTIC ONE NECESSITATES A REVIEW OF THE CURRENT SCIENTIFIC KNOWLEDGE, ADOPTION OF NEW SCIENTIFIC MODELS, AND IDENTIFICATION OF RESEARCH AND KNOWLEDGE GAPS. THE SOSS BROUGHT TOGETHER MULTIDISCIPLINARY STAKEHOLDERS WITH DEEP SCIENTIFIC AND CLINICAL EXPERTISE TO ADDRESS THIS PRESSING NEED.THE THEME OF THE SECOND STATE OF THE SCIENCE SUMMIT, HELD IN 2019 WAS PATHS TO TREATMENT FOR TRAUMATIC BRAIN INJURY(S) WITH A FOCUS ON THE TAXONOMY AND NOSOLOGY OF THE CHRONIC SEQUELAE, CHALLENGES AND OPPORTUNITIES IN CLINICAL PRACTICE AND DEVELOPMENT, AND ETIOLOGY AND MECHANISM OF PERSISTENT SYMPTOMS. AS MEASUREMENT TOOLS ADVANCE, RESEARCH HAS BEEN ABLE TO FOCUS ON DIFFERENT TYPES OF INJURY, BEYOND THE MILD, MODERATE, AND SEVERE CLASSIFICATIONS OF TBI. TO AUGMENT AND SUPPORT THE MANY EFFORTS ACROSS FIELDS AND ORGANIZATIONS OVER THE PAST DECADE, IN 2020 WE WORKED WITH THOUGHT LEADERS ACROSS TBI TO PREPARE A CONSENSUS BLUEPRINT TO DRIVE TRANSLATIONAL SCIENCE FOR TBI. IN 2021, WE PUBLISHED RECOMMENDATIONS IN SUPPORT OF THE NATIONAL TBI PRECISION RESEARCH ROADMAP.IN 2022, WE LAUNCHED THE TBI ACTION ALLIANCE IN SUPPORT OF A NATIONAL TBI PRECISION RESEARCH ROADMAP. THE ROADMAP, BASED ON RECOMMENDATIONS FROM THE BRAIN TRAUMA EXPERT COMMUNITY, OUTLINES A SERIES OF CRITICAL PROJECTS WITH SPECIFIED MILESTONES THAT WILL MATERIALLY ADVANCE PROGRESS TOWARDS THE STATED GOALS OF "ADVANCING A FIRST GENERATION OF TBI DIAGNOSTICS AND TREATMENTS".THE TBI PRECISION RESEARCH ROADMAP FOCUSES ON 7 LINES OF EFFORT:1. INJURY BURDEN: IDENTIFY THE BURDEN OF DISEASE ACROSS ALL POPULATIONS AND INJURY SEVERITIES AS DETERMINED BY INCIDENCE, PREVALENCE AND LONG-TERM TRAJECTORIES OF PATIENTS SUFFERING FROM TBI.2. DISEASE MODELS: DEVELOP AN ARRAY OF TRANSLATIONALLY VALID DISEASE MODELS (PRECLINICAL AND COMPUTATIONAL) BASED ON BIOLOGICAL UNDERSTANDING OF TRAUMA PATHOGENESIS AND DISEASE PHENOTYPES THAT SUPPORT EVALUATION OF NOVEL THERAPIES.3. PRECISION DIAGNOSIS: IDENTIFY, DEVELOP AND VALIDATE DIAGNOSTIC, PROGNOSTIC AND PREDICTIVE BIOMARKERS FORTBI TO DEVELOP FIRST GENERATION DIAGNOSTIC TESTS.4. TARGETED THERAPEUTICS: VALIDATE THERAPEUTIC TARGETS & FAST TRACK A FIRST-GENERATION OF TBI (WELLNESS, DEVICE, DIGITAL, DRUG) THERAPEUTICS TARGETED TO THE RIGHT PERSON AT THE RIGHT TIME.5. CLINICAL PRACTICE IMPLEMENTATION: ACCELERATE ADOPTION OF BEST PRACTICES, CLINICAL PRACTICE GUIDELINES, AND PRECISION THERAPEUTIC APPROACHES TO OPTIMIZE BRAIN HEALTH OUTCOMES.6. TRANSLATIONAL INFRASTRUCTURE AND ENABLINGTECHNOLOGIES: IDENTIFY AND ADDRESS INFRASTRUCTURE,INCENTIVES, REGULATORY AND TECHNOLOGY GAPS TO ADVANCE THE TBI ROADMAP.7. AWARENESS AND ADVOCACY: PLACE TBI AT THE TOP OF THE U.S. PUBLIC POLICY AGENDA AND RAISE AWARENESS TO REDUCE STIGMA OF BRAIN INJURY, ENCOURAGE TREATMENT-SEEKING, AND ENABLE ACCESS AND REIMBURSEMENT OF CARE.IN 2023 WE LAUNCHED THE TBI ACTION ALLIANCE TO SUPPORT THE EXECUTION OF THE NAT |
| IRS990/ProgSrvcAccomActy3Grp/Desc | 0 | STANDARDIZED ADVANCED NEUROIMAGING SCANS ON 3,000 ADULT VOLUNTEERS, THE RESULTING IMAGING DATA, ALONG WITH DEMOGRAPHIC INFORMATION AND THE RESULTS OF NEUROCOGNITIVE ASSESSMENTS, IS FORMING A LIBRARY DOCUMENTING POPULATION VARIATION IN BRAIN STRUCTURE AND FUNCTION AS MEASURED BY THESE ADVANCED IMAGING METHODS.THROUGH THIS IMAGING DATABASE, IT IS OUR GOAL TO ADVANCE NEUROIMAGING TO DRAMATICALLY IMPROVE THE IDENTIFICATION OF AFFECTED INDIVIDUALS AND ALLOW PHYSICIANS TO OBJECTIVELY AND EFFICIENTLY DIAGNOSE CONDITIONS SUCH AS TBI, DEMENTIA AND OTHER BRAIN DISORDERS WHERE BRAIN STRUCTURE IS DETECTED VIA MRI.IN 2022, WE CONTINUED RECRUITMENT INTO THE LIBRARY, REACHING OVER 1,800 ENROLLED SUBJECTS AND ALSO ADDED BLOOD SAMPLE COLLECTION FOR NEWLY RECRUITED INDIVIDUALS. COMPUTATIONAL MODELING & DATA SCIENCES:CVB HAS ESTABLISHED AN INTRAMURAL DATA SCIENCES PROGRAM TO BUILD MACHINE-LEARNING AND ARTIFICIAL INTELLIGENCE BASED PREDICTIVE MODELS OF DISEASE. THESE PROGRAMS BUILD ON OUR ORIGINAL ORION MS BIO-MODELLING PROGRAM AND FOCUSES ON MODELS OF PTSD, TBI, PARKINSONS AND DEMENTIA AND OTHER CONDITIONS.POST-TRAUMATIC STRESS DISORDER ("PSTD") 1.0:OUR MAIN PRIORITY IS TO BUILD A MULTI-MODAL MODEL OF PTSD USING DEEPLY-PHENOTYPED COHORTS SUCH AS THE BEST STUDY AND COHEN VETERANS CENTER STUDIES. IN 2022, WE HAVE BUILT ANALYSIS PIPELINES FOR EPIGENETIC, EEG, INFLAMMATORY MARKER AND CLINICAL DATA AND WE ARE ON TRACK TO BUILD OUR FIRST MODEL BY YEAR END.PARKINSON'S PROGRESSION MARKERS INITIATIVE ("PPMI") DATA SCIENCE MODELING GROUP:EXISTING DIAGNOSES FOR COMPLEX BRAIN DISORDERS SUCH AS PARKINSON'S DISEASE FOCUS ON UNDERSTANDING CLUSTERS OF MAJOR SYMPTOMS. IN ORDER TO DRIVE PROGRESS IN THE DEVELOPMENT OF NEW TREATMENTS, IT IS IMPORTANT TO UNDERSTAND THE ROLE OF SPECIFIC BIOLOGICAL PROCESSES IN DETERMINING PATIENT OUTCOMES. IN THIS PROGRAM, WE MODEL THE MICHAEL J. FOX FOUNDATION ("MJFF") SPONSORED PARKINSON'S PROGRESSION MODEL INITIATIVE STUDY. THE STUDY HAS EVALUATED PARTICIPANTS' CLINICAL STATUS WHILE COLLECTING IMAGING, BEHAVIORAL, 'OMICS AND OTHER ASSESSMENTS LONGITUDINALLY SINCE 2010. IN OUR ALIGNED MISSIONS TO ADVANCE BRAIN HEALTH, MJFF SELECTED CVB'S DATA SCIENCE TEAM TO LEVERAGE THIS COHORT TOGETHER WITH A MULTI-DISCIPLINARY APPROACH TO QUANTITATIVELY EXPLORE, EVALUATE, AND PREDICT DISEASE TRAJECTORY, RISK FACTORS, AND SUBTYPES. GIVEN THE BREADTH AND DEPTH OF THE PPMI DATA AND RICH OPPORTUNITIES TO DEVELOP IMPACTFUL DISEASE MODELS, THE TEAM USE THEIR SUBJECT MATTER EXPERTISE ACROSS TRANSLATIONAL SCIENCE TO GENERATE INSIGHTS FROM 'OMICS, IMAGING, GENETIC AND CLINICAL DATA BY INTEGRATING TECHNIQUES ACROSS ADVANCED STATISTICS, MACHINE LEARNING, AND COMPUTATIONAL MODELING TO FACILITATE PD BIOMARKER DISCOVERY AND DEEPEN OUR UNDERSTANDING OF DISEASE PROGRESSION.MULTIPLE SCLEROSIS ("MS") 1.0:THE ORION BIONETWORKS FLAGSHIP PROGRAM SUCCESSFULLY PILOTED THE ESTABLISHMENT OF A MULTIPLE SCLEROSIS BIONETWORK COMPRISED OF ACADEMIC (NEUROSCIENCE INSTITUTE OF THE BRIGHAM AND WOMEN'S HOSPITAL), ADVOCACY (ACCELERATED CURE PROJECT FOR MS), COMPUTATIONAL (GNS HEALTHCARE, METACELL, THOMSON REUTERS), INFORMATICS (CONVERGE BY DELOITTE, RANCHO BIOSCIENCES, EXAPTIVE), AND ONLINE PATIENT COMMUNITY PARTNERS (PATIENTSLIKEME [PLM]). DE-IDENTIFIED HIPPA-COMPLIANT DATA FROM THREE DATABASES WERE CURATED AND LOADED INTO A CLOUD-BASED DATA KNOWLEDGE MANAGEMENT SYSTEM. THE INTEGRATED REPOSITORY INCLUDES 9,000 SUBJECTS WITH MS AND RELATED CONDITIONS. THE ALLIANCE DEVELOPED A ROADMAP FOR JOINT EXECUTION WITH SPECIFIC SCIENTIFIC AIMS. THE ALLIANCE HAS GENERATED MULTIPLE MODELS BASED ON THE DATA REPOSITORY USING DIFFERENT ALGORITHMIC APPROACHES: PHENOTYPIC PROGNOSTIC MODEL AND TWO MOLECULAR PROGNOSTIC MODELS.PTSD AND TBI PRECLINICAL MODELING PROGRAM:ANIMAL MODELS OF PSYCHIATRIC DISORDERS OFFER A COMPLEMENTARY RESEARCH MODALITY THAT SUPPORTS CLINICAL RESEARCH. IN ORDER TO ACHIEVE A SATISFACTORY DEGREE OF VALIDITY AND RELIABILITY, ANIMAL MODELS OF COMPLEX AND INTRICATE PSYCHIATRIC DI |
| IRS990/ProgSrvcAccomActyOtherGrp/Desc | 0 | FITNESS, IN THIS CONTEXT, IS DEFINED BY THE STAKEHOLDERS, WHO ARE THE SCIENTISTS DIRECTLY INVOLVED IN THE RESEARCH, BUT ALSO THEIR FUNDERS, SPONSORS, PUBLISHERS, RESEARCH TOOL MANUFACTURERS AND COLLABORATION PARTNERS SUCH AS PEERS IN A MULTI-SITE RESEARCH PROJECT. THE ESSENCE OF THE EQIPD QUALITY SYSTEM IS THE SET OF 18 CORE REQUIREMENTS THAT CAN BE ADDRESSED FLEXIBLY, ACCORDING TO USER-SPECIFIC NEEDS AND FOLLOWING A USER-DEFINED TRAJECTORY. THE EQIPD QUALITY SYSTEM PROPOSES GUIDANCE ON EXPECTATIONS FOR QUALITY-RELATED MEASURES, DEFINES CRITERIA FOR ADEQUATE PROCESSES (I.E., PERFORMANCE STANDARDS) AND PROVIDES EXAMPLES OF HOW SUCH MEASURES CAN BE DEVELOPED AND IMPLEMENTED. IN 2023, EQIPD WAS AWARDED A MAJOR GRANT (ISTAND) BY THE INNOVATIVE MEDICINES INITIATIVE IN EUROPE. THERE IS CURRENTLY NO ESTABLISHED FRAMEWORK READILY AVAILABLE OUTSIDE OF SELECTED COMPANIES AND RESEARCH ORGANIZATIONS THAT APPLY INTERNALLY-DEVELOPED STANDARDS AND CRITERIA TO SUPPORT ADEQUATE RESEARCH RIGOR THAT IS COMMENSURATE WITH THE PURPOSE AND APPROPRIATELY ACHIEVABLE. THE GRANT PROGRAM WILL ESTABLISH AND TEST SUCH A FRAMEWORK TO SUPPORT THE PROCESSES OF GENERATING AND REPORTING NONREGULATED RESEARCH RESULTS, AND TO SYSTEMATIZE DECISION-MAKING BASED ON SUCH RESULTS. IT COULD BE APPLIED TO NONREGULATED RESEARCH IN ANY DOMAIN (I.E., RESEARCH NOT CONDUCTED UNDER GOOD PRACTICE GXP STANDARDS SUCH AS GLP), INCLUDING THE DEVELOPMENT OF BIOMARKERS.POLICY & ADVOCACY INITIATIVES:WE ARE COMMITTED TO ADVOCATING FOR POLICY REFORMS AT THE FEDERAL LEVEL THAT BUILD UPON EVIDENCE-BASED PRECISION MEDICINE APPROACHES AND HAVE THE POWER TO BRING NEW SOLUTIONS FOR PTSD AND TBI IN YEARS, NOT DECADES. AS PART OF OUR ADVOCACY EFFORTS, WE CO-FOUNDED THE COALITION TO HEAL INVISIBLE WOUNDS (THE "COALITION"), A COLLABORATIVE INITIATIVE AIMED AT ADVOCATING FOR POLICY REFORMS TO WIDEN AND EXPEDITE THE PIPELINE FOR NEW THERAPIES AND DIAGNOSTICS FOR PTSD AND TBI - WHICH CAN BOTH DRASTICALLY INCREASE THE RISK OF SUICIDE AMONG VETERANS. IN 2023, WE CONTINUE TO GROW MEMBERSHIP IN THE ALLIANCE AS WELL AS CONTRIBUTE TO THE ADVANCEMENT OF SEMINAL LEGISLATION TO SUPPORT VETERANS AND BRAIN RESEARCH. |
| IRS990/ProhibitedTaxShelterTransInd | 0 | 0 |
| IRS990/PYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/PYContributionsGrantsAmt | 0 | 17941055 |
| IRS990/PYExcessBenefitTransInd | 0 | 0 |
| IRS990/PYGrantsAndSimilarPaidAmt | 0 | 501347 |
| IRS990/PYInvestmentIncomeAmt | 0 | 28608 |
| IRS990/PYOtherExpensesAmt | 0 | 9439104 |
| IRS990/PYOtherRevenueAmt | 0 | 112735 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | 558614 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 7547333 |
| IRS990/PYTotalExpensesAmt | 0 | 17523784 |
| IRS990/PYTotalProfFndrsngExpnsAmt | 0 | 36000 |
| IRS990/PYTotalRevenueAmt | 0 | 18082398 |
| IRS990/QuidProQuoContributionsInd | 0 | 0 |
| IRS990/RcvFndsToPayPrsnlBnftCntrctInd | 0 | 0 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | -3997832 |
| IRS990/RegularMonitoringEnfrcInd | 0 | 1 |
| IRS990/RelatedEntityInd | 0 | 0 |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | 0 |
| IRS990/ReportInvestmentsOtherSecInd | 0 | 0 |
| IRS990/ReportLandBuildingEquipmentInd | 0 | 1 |
| IRS990/ReportOtherAssetsInd | 0 | 1 |
| IRS990/ReportOtherLiabilitiesInd | 0 | 1 |
| IRS990/ReportProgramRelatedInvstInd | 0 | 0 |
| IRS990/RevenueAmt | 0 | 0 |
| IRS990/SavingsAndTempCashInvstGrp/BOYAmt | 0 | 3831713 |
| IRS990/SavingsAndTempCashInvstGrp/EOYAmt | 0 | 5471810 |
| IRS990ScheduleA/FactsAndCircumstancesTestTxt | 0 | COHEN VETERANS BIOSCIENCE, INC. ("CVB") IS A PUBLIC CHARITY BIOMEDICAL RESEARCH AND TECHNOLOGY ORGANIZATION DEDICATED TO ADVANCING BRAIN HEALTH BY FAST-TRACKING PRECISION DIAGNOSTICS AND TAILORED THERAPEUTICS. WE ARE LEADING THE WAY TO CURE INVISIBLE WOUNDS FOR THE MILLIONS OF VETERANS, SERVICE MEMBERS, FIRST RESPONDERS, AND CIVILIANS WHO SUFFER FROM TRAUMA-RELATED CONDITIONS, SUCH AS PTSD, TBI AND SUICIDE. GLOBALLY, 2 BILLION INDIVIDUALS ARE DIRECTLY AFFECTED BY BRAIN DISORDERS. THE WORLD HEALTH ORGANIZATION ATTRIBUTES 38% OF THE TOTAL YEARS LOST TO DEATH AND DISABILITY TO BRAIN DISORDERS, A FIGURE WELL AHEAD OF THE NEXT-CLOSEST AND HIGHER-PROFILE DISEASES OF CANCER (12.7%) AND CARDIOVASCULAR DISEASE (11.8%). CVB IS CATALYZING RESEARCH TO ADVANCE BRAIN HEALTH AT ALL STAGES OF SCIENTIFIC DISCOVERY-FROM THEORY TO THERAPEUTIC.THIS MEMO PROVIDES EVIDENCE OF QUANTITATIVE AND QUALITATIVE MEASURES WHICH SUPPORT CONTINUED PUBLIC CHARITY STATUS. CVB MET THE QUANTITATIVE PERCENTAGE TEST CRITERION FOR SUPPORTING FACTS AND CIRCUMSTANCES IN FY23. CVB ENGAGES WITH AND MAKES AVAILABLE TO RESEARCHERS, POLICY MAKERS, AND THE GENERAL PUBLIC A BROAD ARRAY OF PROGRAMS, TOOLS, SERVICES, AND INFORMATION WHICH ADVANCE THE STATE OF BRAIN SCIENCE, GUIDED BY AN INDEPENDENT BOARD AND ADVISORY COUNSELS IN CONJUNCTION WITH CVB'S RENOWNED EXPERTS IN RELEVANT FIELDS OF NEUROSCIENCE, DATA SCIENCE AND PHARMACEUTICAL RESEARCH AND DEVELOPMENT. FOLLOWING ARE MORE DETAILED EVIDENCE OF THESE FACTS AND CIRCUMSTANCES. COHEN VETERANS BIOSCIENCE, INC. EARLY ORIGINS WERE AS AN ORGANIZATION UNDER THE FISCAL SPONSORSHIP OF THE MARIN COUNTY COMMUNITY FOUNDATION, LATER ESTABLISHED AS A STAND-ALONE 501(C)3 IN 2014 UNDER THE NAME ORION BIONETWORKS. CVB'S FOUNDER AND CEO HAS A PERSONAL CONNECTION TO THE PUBLIC WORK THE ORGANIZATION CARRIES OUT BY VIRTUE OF HER HUSBAND BEING A VETERAN OF THE US AIRFORCE SERVICE AND HER SISTER SERVING AS AN AIRFORCE COLONEL, WITH ACTIVE DEPLOYMENTS TO OEF/OIF. THE FORMAL NAME CHANGE TO COHEN VETERANS BIOSCIENCE TOOK PLACE IN 2015 IN CONCERT WITH GENEROUS SEED FUNDING FROM STEVEN A. COHEN. CVB QUALIFIES AS A PUBLIC CHARITY UNDER THE "FACTS AND CIRCUMSTANCES" TEST OF 1.170A-9(F)(3) OF THE TREASURY REGULATIONS, BASED UPON THE FOLLOWING:CVB IS ORGANIZED AND OPERATED SO AS TO ATTRACT NEW AND ADDITIONAL FUNDING ON A CONTINUOUS AND BONA FIDE BASIS; CVB'S CURRENT FUNDRAISING PLANS ARE TARGETED AT A BROAD BASE OF DONORS, INCLUDING FOUNDATIONS, INDIVIDUALS, AND GOVERNMENT AGENCIES. - ONLINE GIVING: CVB HAS HAD A DONATION BUTTON ON ITS WEBSITE AND ALL SOCIAL MEDIA SINCE INCEPTION. AS OF FY22, WE ESTABLISHED REGISTERED STATUS ACROSS ALL 50 STATES. THE ORGANIZATION RUNS SEVERAL ONLINE DONATION CAMPAIGNS THROUGHOUT THE YEAR (E.G. MEMORIAL DAY, VETERANS DAY, GIVING DAY). -FUNDRAISING EVENTS: WE CONTINUE TO GROW OUR REACH TO THE GENERAL PUBLIC THROUGH FUNDRAISING EVENTS, SOME SPONSORED DIRECTLY AND OTHERS ON OUR BEHALF THROUGH OUR AMBASSADOR'S PROGRAM AND ALSO A CROWDRISE CAMPAIGN CAPABILITY WE ADDED TO OUR WEBSITE IN FY23. STARTING IN 2020, WE ENGAGED IN PARTNERSHIPS WITH VETERANS SERVICE ORGANIZATIONS WHO HAVE COMMITTED TO RAISE AWARENESS OF INDIVIDUALLY DRIVEN FUNDRAISING CAMPAIGNS FOR VETERANS PTSD, TBI AND SUICIDE.-MEMBERSHIP PROGRAMS: -IN 2022, WE LAUNCHED AN ANNUAL MEMBERSHIP PROGRAM WITH OTHER NONPROFIT FOUNDATIONS, UNDER OUR COALITION TO HEAL INVISIBLE WOUNDS, TO SUPPORT ADVOCACY AND EDUCATION INITIATIVES. -IN 2023, WE LAUNCHED THE TBI ACTION ALLIANCE PROGRAM WHICH INCLUDES BOTH MEMBERSHIP AND SPONSORSHIP OPPORTUNITIES FOR INDIVIDUALS, PROFESSIONALS, AND INSTITUTIONS TO SUPPORT OUR RESEARCH PROGRAMS TO ADVANCE DIAGNOSTICS AND THERAPEUTICS FOR TRAUMATIC BRAIN INJURIES (TBI). WE HAVE OVER 50 MEMBERS AND INSTITUTIONS ENROLLED TO DATE.-GOVERNMENT & FOUNDATION RESEARCH GRANTS: CVB HAS RECEIVED SUPPORT US GOVERNMENT AGENCIES SUCH AS THE NATIONAL INSTITUTES OF HEALTH AND THE DEPARTMENT OF DEFENSE; A NUMBER OF NONPROFIT ORGANIZATIONS AND FOUNDATIONS INTEREST |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | HRA FORFEITURES - 2020 AMOUNT: $ 28,475. STIMULUS/COVID CREDITS - 2020 AMOUNT: $ 3,629. 2021 AMOUNT: $ 2,480. OTHER REFUNDS - 2021 AMOUNT: $ 110,255. OTHER INCOME - 2022 AMOUNT: $ 37,205. GRANT REFUNDS - 2022 AMOUNT: $ 326,982. |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 1 | DR. HAAS HAS OVER 20 YEARS OF PHARMACEUTICAL EXECUTIVE AND CLINICAL RESEARCH EXPERIENCE INCLUDING DEVELOPMENT LEADERSHIP ROLES IN MEDICAL MARKETING, FULL CLINICAL DEVELOPMENT, EARLY DEVELOPMENT, AND TRANSLATIONAL AND BIOMARKER SCIENCES IN PSYCHIATRY AND NEUROLOGY. DURING HER TENURE AT JOHNSON & JOHNSON, SHE SUCCESSFULLY FILED NDAS IN THE US AND EUROPE FOR RISPERIDONE INDICATIONS IN AUTISM, ADOLESCENT SCHIZOPHRENIA, JUVENILE BIPOLAR DISORDER AND CONDUCT DISORDERS. SHE ALSO LED DEVELOPMENT TEAMS EVALUATING COMPOUNDS FOR DEPRESSION, NEUROPATHIC PAIN, EPILEPSY, AND MIGRAINE DISORDER. SHE SERVED 3 YEARS AS CHIEF SCIENCE AND TECHNOLOGY OFFICER FOR ONE MIND FOR RESEARCH, A NONPROFIT ORGANIZATION LAUNCHED IN MAY 2012 BY PATRICK J KENNEDY. SHE ORCHESTRATED THE LAUNCH OF ONE MIND'S SEMINAL PROGRAMS, APOLLO, AN INFORMATICS RESEARCH PORTAL AND, GEMINI, AN INTERNATIONAL TBI/PTSD RESEARCH PROGRAM. AS AN "INTRAPRENEUR" AT J&J SHE ESTABLISHED THE FIRST NEUROSCIENCE TRANSLATIONAL MEDICINE & INTEGRATIVE SOLUTIONS DEPARTMENT, AND CO-FOUNDED THE FIRST COMPANION DIAGNOSTICS CENTER OF EXCELLENCE AS WELL AS J&J'S HEALTHCARE INNOVATION TEAM. SHE SERVES ON SEVERAL ADVISORY BOARDS INCLUDING ALTO NEUROSCIENCE, KREMBIL CENTRE FOR NEUROINFORMATICS, VIRTUALBRAINCLOUD, PARTNERSHIP FOR ASSESSMENT AND ACCREDITATION OF SCIENTIFIC PRACTICE (PAASP) AND INTERUNIVERSITY MICROELECTRONICS CENTRE (IMEC) AN INTERNATIONAL RESEARCH & DEVELOPMENT AND INNOVATION HUB. DR. HAAS EARNED HER BS IN BIOENGINEERING FROM THE UNIVERSITY OF PENNSYLVANIA, AN MS IN BIOMEDICAL ENGINEERING FROM RUTGERS UNIVERSITY, NEW JERSEY, AND HER MD PHD WITH DISTINCTION IN NEUROSCIENCE FROM ALBERT EINSTEIN COLLEGE OF MEDICINE, NEW YORK. BOARD MEMBER, SECRETARY, THERESA FRANGIOSA HAS EXTENSIVE EXECUTIVE EXPERIENCED BASED ON HER 25 YEAR CAREER WITH THE PHARMACEUTICAL SECTOR. IN HER ROLES WITHIN PHARMA, SHE WAS A GLOBAL LAUNCH LEADER AS WELL AS OVERSEEING EARLY COMMERCIAL STRATEGY IN NEUROSCIENCES. SHE LED LARGE SCALE TEAMS, CROSS-FUNCTIONAL TEAMS TO DEFINE DISEASE AND THERAPEUTIC AREA STRATEGIES FOR JANSSEN AND GLAXOSMITHKLINE. SHE HAS ALSO LED INDICATION PRIORITIZATION EFFORTS AND DEVELOPMENT OF OVER 200 TARGET PRODUCT PROFILES OVER A VARIETY OF DISEASE STATES, LEVERAGING WELL-ESTABLISHED PROCESSES AND FRAMEWORKS, INCLUDING DEEPER UNDERSTANDING OF PATIENT JOURNEYS TO CREATE KEY INSIGHTS. SHE HAS APPLIED HER PROFESSIONAL CAREER EXPERIENCE AND HER PASSION FOR ADVOCACY TO HELP CREATE A CHANNEL FOR FEEDBACK FROM THOSE DIAGNOSED WITH OR AT RISK FOR ALZHEIMER'S DISEASE OR DEMENTIA, THEIR CARE PARTNERS AND INDIVIDUALS WHO ARE 'WORRIED WELL', CALLED THE A-LIST. SHE IS THE LEAD INVESTIGATOR FOR THIS RESEARCH STUDY WITH IRB OVERSIGHT. MS. FRANGIOSA OBTAINED HER BACHELOR OF ADMINISTRATION, ACCOUNTING CONCENTRATION FROM URSINUS COLLEGE (COLLEGEVILLE, PA) IN 1988 AND HER MASTERS OF BUSINESS ADMINISTRATION, PHARMACEUTICAL MARKETING FROM ST. JOSEPH'S UNIVERSITY IN 1996. BOARD MEMBER, TREASURER, MICHAEL C. SULLIVAN IS THE CHIEF OF STAFF AND HEAD OF EXTERNAL AFFAIRS OF POINT72 ASSET MANAGEMENT. MR. SULLIVAN PREVIOUSLY SERVED AS A SENIOR AIDE IN THE UNITED STATES SENATE, FOCUSING ON TELECOM, TECHNOLOGY, AND FINANCE ISSUES. MR. SULLIVAN ALSO SERVED AS A STAFF MEMBER IN THE U.S. HOUSE OF REPRESENTATIVES WORKING ON SIMILAR ISSUES. BEFORE COMING TO CAPITOL HILL, MR. SULLIVAN WAS THE HEAD OF STRATEGIC DEVELOPMENT FOR A TELECOMMUNICATIONS FOCUSED TRADE ASSOCIATION. MR. SULLIVAN IS INVOLVED WITH SEVERAL VETERANS' MENTAL HEALTH-RELATED NONPROFIT ORGANIZATIONS. HE HELPED ESTABLISH AND SERVES ON THE BOARD AND AS TREASURER OF THE COHEN VETERANS NETWORK, WHICH OPERATES A NATIONAL NETWORK OF CLINICS TO TREAT VETERANS AND THEIR FAMILY MEMBERS AFFECTED BY POST-TRAUMATIC STRESS. MR. SULLIVAN IS AN ASSOCIATE AT THE NYU-STERN ENDLESS FRONTIER LABS, WHERE HE MENTORS START-UP COMPANIES IN ARTIFICIAL INTELLIGENCE, MACHINE LEARNING, AND RELATED FIELDS. HE IS ALSO A MEMBER OF THE EXECUTIVE COMMITTEE OF STUDENTS FIRST NEW YORK, A NONPROFIT O |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 1 | PART II SECT C LINE 17A FACTS & CIRCUMSTANCES TEST (CONT): |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt | 0 | 10755381 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt | 0 | 17941055 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 16160581 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 16316026 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 20795052 |
| IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt | 0 | 81968095 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt | 0 | 223966 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt | 0 | 28608 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 59585 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt | 0 | 154639 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt | 0 | 98872 |
| IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt | 0 | 565670 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt | 0 | 364187 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt | 0 | 112735 |
| IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt | 0 | 32104 |
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2023 • Form 990Detailed filing. Detailed filing data is available for this year.
Similar nonprofits based on the same Siviq industry and scale cohort. 2023 filings • 501(c)3 • $10M-$25M nonprofits
Boston, MA
View Organization501(c)3
Revenue vs current organization
47% lowerAssets vs current organization
About the sameInman, KS
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
13% lowerSeattle, WA
View Organization501(c)3
Revenue vs current organization
9.7% lowerAssets vs current organization
About the sameRichmond, CA
View Organization501(c)3
Revenue vs current organization
34% lowerAssets vs current organization
About the same